🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jessica Yang

ORCID: 0009-0003-5735-7860

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial”.

First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial

The Lancet Oncology(2023)10.1016/s1470-2045(23)00358-3

N/A

1.5DataRank · unranked

45 citations

Ryan H. Moy, Darren Cowzer, Ronak Shah, Joanne F. Chou, Smita S. Joshi +25 more

Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000331

N/A

0.725DataRank · unranked

125 citations

Kristina Navrazhina, Fei Ding, Roma Bhatia, Katy K. Tsai, Kelly Abbate +23 more

Multiregional genetic evolution of metastatic uveal melanoma

npj Genomic Medicine(2021)10.1038/s41525-021-00233-5

N/A

0DataRank · unranked

11 citations

Jessica Yang, Michael Durante, Alexander N. Shoushtari, Stergios J. Moschos, Kazimierz O. Wrzeszczyński +3 more

Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease

Inflammatory Bowel Diseases(2023)10.1093/ibd/izad196

N/A

0DataRank · unranked

17 citations

Vanessa Mitsialis, David Y. Kim, Mairead Bresnahan, Jessica Yang, Margaret Tuthill +12 more